{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:21:54Z","timestamp":1792272114416,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T00:00:00Z","timestamp":1434067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00198-015-3189-8","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T13:55:33Z","timestamp":1434030933000},"page":"2785-2791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Treatment with intermittent PTH increases Wnt10b production by T cells in osteoporotic patients"],"prefix":"10.1007","volume":"26","author":[{"given":"P.","family":"D\u2019Amelio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Buondonno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fornelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Spertino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lucchiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Roato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. C.","family":"Isaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,12]]},"reference":[{"key":"3189_CR1","first-page":"801","volume":"34","author":"BC Silva","year":"2011","unstructured":"Silva BC, Costa AG, Cusano NE, Kousteni S, Bilezikian JP (2011) Catabolic and anabolic actions of parathyroid hormone on the skeleton. J Endocrinol Investig 34:801\u2013810. doi: 10.3275\/7925","journal-title":"J Endocrinol Investig"},{"key":"3189_CR2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1359\/jbmr.070413","volume":"22","author":"P Chen","year":"2007","unstructured":"Chen P, Miller PD, Recker R, Resch H, Rana A, Pavo I, Sipos AA (2007) Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis. J Bone Miner Res 22:1173\u20131180","journal-title":"J Bone Miner Res"},{"key":"3189_CR3","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"3189_CR4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-146-5-200703060-00005","volume":"146","author":"SL Greenspan","year":"2007","unstructured":"Greenspan SL, Bone HG, Ettinger MP et al (2007) Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 146:326\u2013339","journal-title":"Ann Intern Med"},{"key":"3189_CR5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1034\/j.1600-0625.2003.00068.x","volume":"12","author":"M Thomson","year":"2003","unstructured":"Thomson M, McCarroll J, Bond J, Gordon-Thomson CD, Williams E, Moore GP (2003) Parathyroid hormone-related peptide modulates signal pathways in skin and hair follicle cells. Exp Dermatol 12:389\u2013395","journal-title":"Exp Dermatol"},{"key":"3189_CR6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/pr.114.009464","volume":"67","author":"TJ Gardella","year":"2015","unstructured":"Gardella TJ, Vilardaga JP (2015) International union of basic and clinical pharmacology. XCIII. The parathyroid hormone receptors-family B G protein-coupled receptors. Pharmacol Rev 67:310\u2013337. doi: 10.1124\/pr.114.009464","journal-title":"Pharmacol Rev"},{"key":"3189_CR7","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.RES.0000248184.21644.20","volume":"99","author":"N Fiaschi-Taesch","year":"2006","unstructured":"Fiaschi-Taesch N, Sicari BM, Ubriani K, Bigatel T, Takane KK, Cozar-Castellano I, Bisello A, Law B, Stewart AF (2006) Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP\/p27kip1 pathway. Circ Res 99:933\u2013942","journal-title":"Circ Res"},{"key":"3189_CR8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1359\/jbmr.2002.17.3.455","volume":"17","author":"C Faucheux","year":"2002","unstructured":"Faucheux C, Horton MA, Price JS (2002) Nuclear localization of type I parathyroid hormone\/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone. J Bone Miner Res 17:455\u2013464","journal-title":"J Bone Miner Res"},{"key":"3189_CR9","doi-asserted-by":"crossref","first-page":"20122","DOI":"10.1074\/jbc.M112.441360","volume":"288","author":"V Saini","year":"2013","unstructured":"Saini V, Marengi DA, Barry KJ, Fulzele KS, Heiden E, Liu X, Dedic C, Maeda A, Lotinun S, Baron R, Pajevic PD (2013) Parathyroid hormone (PTH)\/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. J Biol Chem 288:20122\u201320134. doi: 10.1074\/jbc.M112.441360","journal-title":"J Biol Chem"},{"key":"3189_CR10","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1359\/jbmr.070804","volume":"22","author":"O Leupin","year":"2007","unstructured":"Leupin O, Kramer I, Collette NM, Loots GG, Natt F, Kneissel M, Keller H (2007) Control of the SOST bone enhancer by PTH using MEF2 transcription factors. J Bone Miner Res 22:1957\u20131967","journal-title":"J Bone Miner Res"},{"key":"3189_CR11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jbmr.1492","volume":"27","author":"I Kramer","year":"2012","unstructured":"Kramer I, Baertschi S, Halleux C, Keller H, Kneissel M (2012) Mef2c deletion in osteocytes results in increased bone mass. J Bone Miner Res 27:360\u2013373. doi: 10.1002\/jbmr.1492","journal-title":"J Bone Miner Res"},{"key":"3189_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jcb.22559","volume":"110","author":"DC Genetos","year":"2010","unstructured":"Genetos DC, Toupadakis CA, Raheja LF, Wong A, Papanicolaou SE, Fyhrie DP, Loots GG, Yellowley CE (2010) Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts. J Cell Biochem 110:457\u2013467. doi: 10.1002\/jcb.22559","journal-title":"J Cell Biochem"},{"key":"3189_CR13","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1073\/pnas.1207188109","volume":"109","author":"NM Collette","year":"2012","unstructured":"Collette NM, Genetos DC, Economides AN, Xie L, Shahnazari M, Yao W, Lane NE, Harland RM, Loots GG (2012) Targeted deletion of Sost distal enhancer increases bone formation and bone mass. Proc Natl Acad Sci U S A 109:14092\u201314097. doi: 10.1073\/pnas.1207188109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3189_CR14","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1210\/jc.2010-0720","volume":"95","author":"MT Drake","year":"2010","unstructured":"Drake MT, Srinivasan B, M\u00f6dder UI, Peterson JM, McCready LK, Riggs BL, Dwyer D, Stolina M, Kostenuik P, Khosla S (2010) Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab 95:5056\u20135062. doi: 10.1210\/jc.2010-072","journal-title":"J Clin Endocrinol Metab"},{"key":"3189_CR15","first-page":"866","volume":"35","author":"S Piemonte","year":"2012","unstructured":"Piemonte S, Romagnoli E, Bratengeier C, Woloszczuk W, Tancredi A, Pepe J, Cipriani C, Minisola S (2012) Serum sclerostin levels decline in post-menopausal women with osteoporosis following treatment with intermittent parathyroid hormone. J Endocrinol Investig 35:866\u2013868. doi: 10.3275\/8522","journal-title":"J Endocrinol Investig"},{"key":"3189_CR16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.maturitas.2014.04.013","volume":"78","author":"SC Manolagas","year":"2014","unstructured":"Manolagas SC (2014) Wnt signaling and osteoporosis. Maturitas 78:233\u2013237. doi: 10.1016\/j.maturitas.2014.04.013","journal-title":"Maturitas"},{"key":"3189_CR17","doi-asserted-by":"crossref","first-page":"E725","DOI":"10.1073\/pnas.1120735109","volume":"109","author":"B Bedi","year":"2012","unstructured":"Bedi B, Li JY, Tawfeek H, Baek KH, Adams J, Vangara SS, Chang MK, Kneissel M, Weitzmann MN, Pacifici R (2012) Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH. Proc Natl Acad Sci U S A 109:E725\u2013E733. doi: 10.1073\/pnas.1120735109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3189_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cmet.2009.07.010","volume":"10","author":"M Terauchi","year":"2009","unstructured":"Terauchi M, Li JY, Bedi B, Baek KH, Tawfeek H, Galley S, Gilbert L, Nanes MS, Zayzafoon M, Guldberg R, Lamar DL, Singer MA, Lane TF, Kronenberg HM, Weitzmann MN, Pacifici R (2009) T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling. Cell Metab 10:229\u2013240. doi: 10.1016\/j.cmet.2009.07.010","journal-title":"Cell Metab"},{"key":"3189_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jbmr.2044","volume":"29","author":"JY Li","year":"2014","unstructured":"Li JY, Walker LD, Tyagi AM, Adams J, Weitzmann MN, Pacifici R (2014) The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b. J Bone Miner Res 29:43\u201354. doi: 10.1002\/jbmr.2044","journal-title":"J Bone Miner Res"},{"key":"3189_CR20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00223-012-9665-7","volume":"92","author":"O Viapiana","year":"2013","unstructured":"Viapiana O, Fracassi E, Troplini S, Idolazzi L, Rossini M, Adami S, Gatti D (2013) Sclerostin and DKK1 in primary hyperparathyroidism. Calcif Tissue Int 92:324\u2013329. doi: 10.1007\/s00223-012-9665-7","journal-title":"Calcif Tissue Int"},{"key":"3189_CR21","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00198-011-1806-8","volume":"23","author":"MS Ardawi","year":"2012","unstructured":"Ardawi MS, Al-Sibiany AM, Bakhsh TM, Rouzi AA, Qari MH (2012) Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study. Osteoporos Int 23:1789\u20131797. doi: 10.1007\/s00198-011-1806-8","journal-title":"Osteoporos Int"},{"key":"3189_CR22","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","volume":"146","author":"T Bellido","year":"2005","unstructured":"Bellido T, Ali AA, Gubrij I, Plotkin LI, Fu Q, O\u2019Brien CA, Manolagas SC, Jilka R (2005) Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 146:4577\u20134583","journal-title":"Endocrinology"},{"key":"3189_CR23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jbmr.5650070808","volume":"7","author":"M Parisien","year":"1992","unstructured":"Parisien M, Mellish RW, Silverberg SJ, Shane E, Lindsay R, Bilezikian JP, Dempster DW (1992) Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Miner Res 7:913\u2013919","journal-title":"J Bone Miner Res"},{"key":"3189_CR24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","volume":"70","author":"M Parisien","year":"1990","unstructured":"Parisien M, Silverberg SJ, Shane E, de la Cruz L, Lindsay R, Bilezikian JP, Dempster DW (1990) The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 70:930\u2013938","journal-title":"J Clin Endocrinol Metab"},{"key":"3189_CR25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/jbmr.5650100917","volume":"10","author":"M Parisien","year":"1995","unstructured":"Parisien M, Cosman F, Mellish RW et al (1995) Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Miner Res 10:1393\u20131399","journal-title":"J Bone Miner Res"},{"key":"3189_CR26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s007740050096","volume":"17","author":"T Uchiyama","year":"1999","unstructured":"Uchiyama T, Tanizawa T, Ito A, Endo N, Takahashi HE (1999) Microstructure of the trabecula and cortex of iliac bone in primary hyperparathyroidism patients determined using histomorphometry and node-strut analysis. J Bone Miner Metab 17:283\u2013288","journal-title":"J Bone Miner Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3189-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-015-3189-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3189-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T13:10:17Z","timestamp":1717938617000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-015-3189-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["3189"],"URL":"https:\/\/doi.org\/10.1007\/s00198-015-3189-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,12]]}}}